Bayesian two‐stage sequential enrichment design for biomarker‐guided phase II trials for anticancer therapies (Q6068829)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Bayesian two‐stage sequential enrichment design for biomarker‐guided phase II trials for anticancer therapies |
scientific article; zbMATH DE number 7779218
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bayesian two‐stage sequential enrichment design for biomarker‐guided phase II trials for anticancer therapies |
scientific article; zbMATH DE number 7779218 |
Statements
Bayesian two‐stage sequential enrichment design for biomarker‐guided phase II trials for anticancer therapies (English)
0 references
15 December 2023
0 references
Bayesian hierarchical model
0 references
borrow information
0 references
enrichment design
0 references
phase II clinical trial
0 references
targeted therapy
0 references
